BioNTech gets funding for Kenyan vaccine facility
BioNTech has signed up to €95 million ($110 million) in blended financing from EIB and the European Commission to advance its mRNA vaccine...
BioNTech has signed up to €95 million ($110 million) in blended financing from EIB and the European Commission to advance its mRNA vaccine...